1. Home
  2. NVO vs ASML Comparison

NVO vs ASML Comparison

Compare NVO & ASML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • ASML
  • Stock Information
  • Founded
  • NVO 1923
  • ASML 1984
  • Country
  • NVO Denmark
  • ASML Netherlands
  • Employees
  • NVO N/A
  • ASML N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • ASML Industrial Machinery/Components
  • Sector
  • NVO Health Care
  • ASML Technology
  • Exchange
  • NVO Nasdaq
  • ASML Nasdaq
  • Market Cap
  • NVO 278.0B
  • ASML 265.4B
  • IPO Year
  • NVO N/A
  • ASML 1995
  • Fundamental
  • Price
  • NVO $65.73
  • ASML $706.21
  • Analyst Decision
  • NVO Strong Buy
  • ASML Buy
  • Analyst Count
  • NVO 4
  • ASML 6
  • Target Price
  • NVO $128.00
  • ASML $918.00
  • AVG Volume (30 Days)
  • NVO 11.2M
  • ASML 1.5M
  • Earning Date
  • NVO 05-07-2025
  • ASML 04-16-2025
  • Dividend Yield
  • NVO 2.45%
  • ASML 0.96%
  • EPS Growth
  • NVO 17.93
  • ASML 22.60
  • EPS
  • NVO 3.40
  • ASML 23.97
  • Revenue
  • NVO $43,922,211,349.00
  • ASML $33,269,497,396.00
  • Revenue This Year
  • NVO $20.22
  • ASML $15.58
  • Revenue Next Year
  • NVO $16.10
  • ASML $9.55
  • P/E Ratio
  • NVO $19.32
  • ASML $29.39
  • Revenue Growth
  • NVO 24.11
  • ASML 17.67
  • 52 Week Low
  • NVO $57.00
  • ASML $578.51
  • 52 Week High
  • NVO $148.15
  • ASML $1,110.09
  • Technical
  • Relative Strength Index (RSI)
  • NVO 48.22
  • ASML 58.44
  • Support Level
  • NVO $64.40
  • ASML $675.50
  • Resistance Level
  • NVO $69.67
  • ASML $716.81
  • Average True Range (ATR)
  • NVO 1.74
  • ASML 12.72
  • MACD
  • NVO 0.85
  • ASML 6.77
  • Stochastic Oscillator
  • NVO 62.20
  • ASML 87.65

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About ASML ASML Holding N.V. New York Registry Shares

ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's main clients are TSMC, Samsung, and Intel.

Share on Social Networks: